There's been a flurry of recent activity in the direct-to-consumer space as drug costs and spending continues to rise. | LOS ...

GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced the launch of GoodRx ...

GoodRx Holdings, Inc. recently reported fourth-quarter 2025 revenue of US$194.79 million and full-year revenue of US$796.85 million, alongside the launch of GoodRx Employer Direct to help employers ...

GoodRx Holdings, Inc. ( GDRX) Q4 2025 Earnings Call February 26, 2026 8:00 AM EST Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx Fourth Quarter and Full Year 2025 Earnings ...

TrumpRx is primarily for people who pay for their prescriptions out-of-pocket. There may be cheaper generic options at direct ...

The Trump administration's new website, TrumpRx, is a poor imitation of GoodRx with fewer options, and does not provide real ...

The Trump administration's new website, TrumpRx, is a poor imitation of GoodRx with fewer options, and does not provide real relief for families struggling with high drug prices.

The list price of Wegovy will be cut in half on January 1, 2027, plummeting from around $1,350 to $675 a month. The cost of ...

Healthcare tech company GoodRx (NASDAQ:GDRX) will be announcing earnings results this Wednesday after the bell. Here’s what ...

Fourth Quarter and Full Year 2025 Revenue and Adjusted EBITDA Results In-line with Previous Guidance Pharma Direct Revenue Beats Previous Outlook with Over 40% Year-Over-Year Growth for 2025SANTA ...

At first glance, the website the Trump administration launched on Feb. 5 appears to be a solid effort to address the health care affordability crisis affecting millions of Americans. Dubbed ...

Q. My husband got COVID last fall. He has had great success from Paxlovid in the past, when he got it for free during the pandemic. This time he was charged $800 on his Medicare Drug Plan. That seems ...